3 Results for "

reinforcing effects

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "reinforcing effects" in MCE Product Catalog:

Cat. No.: HY-135608
CAS No.: 138356-08-8
Purity:  98.41%
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

BD-1008 is a nonselective σ receptor antagonist with Kis against σ1 receptor and σ2 receptor of 2 nM and 8 nM. The BD-1008 has an extremely low affinity for the D2 receptor (Ki = 1112 nM) and dopamine transporter (DAT) (Ki > 10,000 nM). BD-1008 significantly antagonizes dopamine release in the shell region of the nucleus accumbens via the σ₂ receptor. BD-1008 blocks the self-administration behavior of σ agonists.BD-1008 can be used for the study of addiction therapy that target the σ receptor .
loading...
    loading...
Cat. No.: HY-121870
CAS No.: 94-15-5
Purity:  99.90%
Synonyms: Larocaine
Research Areas:  

Neurological Disease

Dimethocaine (Larocaine) is a cocaine derivative and ester-type local anesthetic. Dimethocaine is metabolized by hP450 1A2, 2C19, 2D6, and 3A4 in vitro. Dimethocaine exhibits locomotor-promoting, reinforcing, and anxiogenic effects .
loading...
    loading...
Cat. No.: HY-100966
CAS No.: 138356-09-9
Purity:  98.07%
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

BD-1008 dihydrobromide is a nonselective σ receptor antagonist with Kis against σ1 receptor and σ2 receptor of 2 nM and 8 nM. The BD-1008 dihydrobromide has an extremely low affinity for the D2 receptor (Ki = 1112 nM) and dopamine transporter (DAT) (Ki > 10,000 nM). BD-1008 dihydrobromide significantly antagonizes dopamine release in the shell region of the nucleus accumbens via the σ₂ receptor. BD-1008 dihydrobromide blocks the self-administration behavior of σ agonists.BD-1008 dihydrobromide can be used for the study of addiction therapy that target the σ receptor .
loading...
    loading...